Skip to main content

Table 1 A structured review of published literature estimating HCV prevalence in prisoners in 5 European countries

From: Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe

Country

HCV prevalence

Year of study

Study type

Sample Size, N

N, Prisons

Note

Author, Year (ref)

Ab (%)

RNA (%)

Spain

12.8

9.9

2017

Cross-sectional

821

1

Cantabria – El Dueso prison

Crespo 2017 [49]

Nr

9.1

2017

Regional screening

7051

10

Cataluña

Gencat 2018 [50]

11.0

8.8

2016

Cross-sectional

1264

10

Cataluña

Marco 2017 [51]

18.7

11.0

2016

Aggregation of regional statistics

48,830

nr

National data used

Ministry of Interior 2017 [52]

17.6

9.9

2016

Cross-sectional

204

3

Andalucía

Tellez 2017 [53]

22.7

20.1

2008

Cross-sectional

378

18

Spain

Saiz de la Hoya [54]

34.2

nr

2008

Cross-sectional

730

1

Spain

Murcia 2009 [55]

England

18.0

15.0

2014

HJIPS opt out testing programme

8797

112

England

Public Health England 2017 [43]

8.0

nr

2014

PHE Sentinel surveillance

4089

Multiple, figure not mentioned

Data not specified

Public Health England 2015 [56]

43.0

28.0

2013–2014

Observational

102

1

Northumberland

Darke 2015 [57]

19.0

nr

2012

Cross-sectional

4904

14

Scotland

Taylor 2012 [58]

11.0

nr

2010–2011

Retrospective analysis

118

1

Oxfordshire

Duncan 2013 [59]

24.0

11.0

2005–2008

Retrospective analysis from sentinel survey

9965

39

England; (N = 1490* Ab+ tested for RNA)

Kirwan 2011 [60]

France

15.0

nr

2017

Survey

950

1

Maison d’Arrêt de Villeneuve-les-Maguelone

Meroueh 2017 [61]

5.0

2.0

2012–2013

Cross-sectional

342

2

Puy-de-Dome

Jacomet 2016 [62]

4.8 (Women 11.8; Men 4.5)

2.5

2010

Cross-sectional, questionnaire-based

1876

27

Prisons stratification by region and prison type for selection

Semaille 2013 [63]

13.0

nr

2008

Survey

nr

1

Maison d’Arrêt de Villeneuve-les-Maguelone

Meroueh 2008 [64]

5.0

nr

2004–2010

Cross-sectional questionnaire (multiple time points)

5957

3

Southeastern France

Roux 2014 [65]

5.0

nr

2000–2003

Cross-sectional

597

1

Caen

Verneuil 2009 [66]

Italy

Nr

7.4

2014

Survey, questionnaire-based

15,751

57

6 regions: Toscana, Lazio, Veneto, Liguria, Umbria, ASL Salerno

Agenzia Regionale di Sanità dellaToscana [67]

22.8

nr

2009

Cross-sectional

2241

9

Representative sample of prisons selected based on geographical location

Sagnelli 2012 [68]

22.0

19.0

2006

Cross-sectional

695

1

Milan-Opera

Brandolini 2013 [69]

28.0

nr

2001–2002

Cross-sectional

1091

3

Cassino, Frosinone, Latina

La Torre 2012 [70]

9.0

nr

2006–2009

Cross-sectional

na

na

Toscana

Voller 2011 [71]

Germany

16.0

nr

2006–2007

Cross-sectional survey analysis

1582

6

Chemnitz, Hameln, Köln, Remscheid, Rheinbach, Zeithain

Eckert & Weilandt 2008 [72]

16.0

nr

2006–2007

Cross-sectional (Serology + questionnaire)

1519

6

Closed German institutions

Radun 2007 [73]

14.0

nr

2006

Survey, questionnaire-based

14,187

31

Based on return of completed survey from prison physicians

Schulte 2009 [74]

9.0

7.0

2002

Cross-sectional

1125

1

German Young Offenders’ Institution

Meyer 2007 [75]

  1. nr not reported